{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:35:04Z","timestamp":1791754504085,"version":"4.3.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jcrt.jcrt_702_18","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T06:25:01Z","timestamp":1580279101000},"page":"559-564","source":"Crossref","is-referenced-by-count":10,"title":["Metronomic palliative chemotherapy in locally advanced, recurrent and metastatic head-and-neck cancer"],"prefix":"10.4103","volume":"16","author":[{"given":"Kamlesh Kumar","family":"Harsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sita Ram","family":"Maharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj Kumar","family":"Nirban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramila","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surenderkumar","family":"Beniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvinder Singh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar Lal","family":"Jakhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20230619","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7314\/APJCP.2014.15.2.537","article-title":"Head and neck cancer: Global burden and regional trends in India","volume":"15","author":"Mishra","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R2-25-20230619","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archotol.130.1.35","article-title":"Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: Is salvage possible?","volume":"130","author":"Gleich","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R3-25-20230619","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1200\/JCO.2005.05.3348","article-title":"Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck","volume":"24","author":"Colevas","year":"2006","journal-title":"J Clin Oncol"},{"key":"R4-25-20230619","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI9872","article-title":"Less is more, regularly: Metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice","volume":"105","author":"Hanahan","year":"2000","journal-title":"J Clin Invest"},{"key":"R6-25-20230619","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R7-25-20230619","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/74969","article-title":"Chemotherapeutic drugs \u2013 More really is not better","volume":"6","author":"Fidler","year":"2000","journal-title":"Nat Med"},{"key":"R8-25-20230619","first-page":"1878","article-title":"Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer","volume":"60","author":"Browder","year":"2000","journal-title":"Cancer Res"},{"key":"R9-25-20230619","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI8829","article-title":"Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity","volume":"105","author":"Klement","year":"2000","journal-title":"J Clin Invest"},{"key":"R10-25-20230619","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrclinonc.2010.82","article-title":"Metronomic chemotherapy: New rationale for new directions","volume":"7","author":"Pasquier","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"R11-25-20230619","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mpo.2950220205","article-title":"Methotrexate content in squamous cell carcinoma of the head and neck after low-dose methotrexate","volume":"22","author":"Schifeling","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"R12-25-20230619","first-page":"S106","article-title":"Metronomic chemotherapy in advanced oral cancers","volume":"8 Suppl 1","author":"Patil","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"R13-25-20230619","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1186\/s12885-015-1705-z","article-title":"Head and neck cancer: Metronomic chemotherapy","volume":"15","author":"De Felice","year":"2015","journal-title":"BMC Cancer"},{"key":"R14-25-20230619","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0019-509X.117024","article-title":"Oral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: A matched-pair analysis","volume":"50","author":"Pai","year":"2013","journal-title":"Indian J Cancer"},{"key":"R15-25-20230619","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1158\/0008-5472.CAN-06-3780","article-title":"Celecoxib toxicity is cell cycle phase specific","volume":"67","author":"Bock","year":"2007","journal-title":"Cancer Res"},{"key":"R16-25-20230619","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000","journal-title":"Cancer Res"},{"key":"R17-25-20230619","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000071373","article-title":"Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis","volume":"37","author":"Gately","year":"2003","journal-title":"Prog Exp Tumor Res"},{"key":"R18-25-20230619","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/bjc.2011.154","article-title":"Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer","volume":"104","author":"Khan","year":"2011","journal-title":"Br J Cancer"},{"key":"R19-25-20230619","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"R21-25-20230619","first-page":"219","article-title":"Oral metronomic chemotherapy in recurrent metastatic and locally advanced head and neck cancers","volume":"400","author":"Patil","year":"2017","journal-title":"J Clin Oncol"},{"key":"R22-25-20230619","first-page":"37","article-title":"Metronomic chemotherapy in advanced\/recurrent head and neck cancer: A tertiary centre experience","volume":"5","author":"Kalaichelvi","year":"2016","journal-title":"South Asian J Cancer"},{"key":"R24-25-20230619","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/2278-330X.181626","article-title":"Metronomic palliative chemotherapy in maxillary sinus tumor","volume":"5","author":"Patil","year":"2016","journal-title":"South Asian J Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_702_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:27:04Z","timestamp":1786735624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_702_18"}},"subtitle":["A single-arm, retrospective study of a regional cancer center of North India (Asia)"],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_702_18","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}